CXCL1 and neoplasm: Unlike the cancer drivers mentioned above, based on the current evidence, F. nucleatum is a “passenger”19 bacteria that colonizes an already formed tumor and accelerates its progression through manipulation of β‐catenin signaling,43, 44 host cytokine production (IL‐8 and CXCL1),134 anti‐tumor immunity, and chemoresistance.